RDEA3170 PK/PD Study

NCT02608710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: RDEA3170 4.5 mg
DRUG: RDEA3170 6 mg
DRUG: RDEA3170 12 mg

Sponsor

Ardea Biosciences, Inc.